<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34439885</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom11081220</ELocationID><Abstract><AbstractText>The pathogenesis of amyotrophic lateral sclerosis (ALS), a lethal neurodegenerative disease, remains undisclosed. Mutations in ALS related genes have been identified, albeit the majority of cases are unmutated. Clinical pathology of ALS suggests a prion-like cell-to-cell diffusion of the disease possibly mediated by exosomes, small endocytic vesicles involved in the propagation of RNA molecules and proteins. In this pilot study, we focused on exosomal microRNAs (miRNAs), key regulators of many signaling pathways. We analyzed serum-derived exosomes from ALS patients in comparison with healthy donors. Exosomes were obtained by a commercial kit. Purification of miRNAs was performed using spin column chromatography and RNA was reverse transcribed into cDNA. All samples were run on the miRCURY LNA<sup>TM</sup> Universal RT miRNA PCR Serum/Plasma Focus panel. An average of 29 miRNAs were detectable per sample. The supervised analysis did not identify any statistically significant difference among the groups indicating that none of the miRNA of our panel has a strong pathological role in ALS. However, selecting samples with the highest miRNA content, six biological processes shared across miRNAs through the intersection of the GO categories were identified. Our results, combined to those reported in the literature, indicated that further investigation is needed to elucidate the role of exosome-derived miRNA in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pregnolato</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0574-5792</Identifier><AffiliationInfo><Affiliation>Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Cusano Milanino, 20095 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cova</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1504-1556</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doretti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardelli</LastName><ForeName>Donatella</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3089-0019</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Dino Ferrari" Center, Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bossolasco</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">exosome</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword><Keyword MajorTopicYN="N">serum</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34439885</ArticleId><ArticleId IdType="pmc">PMC8394507</ArticleId><ArticleId IdType="doi">10.3390/biom11081220</ArticleId><ArticleId IdType="pii">biom11081220</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455:1124&#x2013;1128. doi: 10.1038/nature07299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07299</ArticleId><ArticleId IdType="pubmed">18806776</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien J., Hayder H., Zayed Y., Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 2018;9:402. doi: 10.3389/fendo.2018.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoicea N., Du A., Lakis C.D., Tipton C., Arias-Morales C.E., Bergese S.D. The miRNA journey from theory to practice as a CNS biomarker. Front. Genet. 2016;7:11. doi: 10.3389/fgene.2016.00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2016.00011</ArticleId><ArticleId IdType="pmc">PMC4746307</ArticleId><ArticleId IdType="pubmed">26904099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Reddy P.H. Are circulating microRNAs peripheral biomarkers for Alzheimer&#x2019;s disease? Biochim. Biophys. Acta-Mol. Basis Dis. 2016;1862:1617&#x2013;1627. doi: 10.1016/j.bbadis.2016.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.06.001</ArticleId><ArticleId IdType="pmc">PMC5343750</ArticleId><ArticleId IdType="pubmed">27264337</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhao J., Evan G., Xiao C., Cheng Y., Xiao J. Circulating microRNAs: Novel biomarkers for cardiovascular diseases. J. Mol. Med. 2012;90:865&#x2013;875. doi: 10.1007/s00109-011-0840-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-011-0840-5</ArticleId><ArticleId IdType="pubmed">22159451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryzgunova O., Konoshenko M., Zaporozhchenko I., Yakovlev A., Laktionov P. Isolation of cell-free mirna from biological fluids: Influencing factors and methods. Diagnostics. 2021;11:865. doi: 10.3390/diagnostics11050865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11050865</ArticleId><ArticleId IdType="pmc">PMC8151063</ArticleId><ArticleId IdType="pubmed">34064927</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijnen H.F.G., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and &#x3b1;-granules. Blood. 1999 doi: 10.1182/blood.V94.11.3791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V94.11.3791</ArticleId><ArticleId IdType="pubmed">10572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Zitvogel L., Amigorena S. Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol. 2002;2:569&#x2013;579. doi: 10.1038/nri855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri855</ArticleId><ArticleId IdType="pubmed">12154376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung I.M., Rajakumar G., Venkidasamy B., Subramanian U., Thiruvengadam M. Exosomes: Current use and future applications. Clin. Chim. Acta. 2020;500:226&#x2013;232. doi: 10.1016/j.cca.2019.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2019.10.022</ArticleId><ArticleId IdType="pubmed">31678573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo A., Tandon M., Alevizos I., Illei G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE. 2012;7:e30679. doi: 10.1371/journal.pone.0030679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030679</ArticleId><ArticleId IdType="pmc">PMC3302865</ArticleId><ArticleId IdType="pubmed">22427800</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadi H., Ekstr&#xf6;m K., Bossios A., Sj&#xf6;strand M., Lee J.J., L&#xf6;tvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007;9:654&#x2013;659. doi: 10.1038/ncb1596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1596</ArticleId><ArticleId IdType="pubmed">17486113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori M.A., Ludwig R.G., Garcia-Martin R., Brand&#xe3;o B.B., Kahn C.R. Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. Cell Metab. 2019;30:656&#x2013;673. doi: 10.1016/j.cmet.2019.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.07.011</ArticleId><ArticleId IdType="pmc">PMC6774861</ArticleId><ArticleId IdType="pubmed">31447320</ArticleId></ArticleIdList></Reference><Reference><Citation>Faur&#xe9; J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., Grange J., Schoehn G., Goldberg Y., Boyer V., et al. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 2006;31:642&#x2013;648. doi: 10.1016/j.mcn.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.12.003</ArticleId><ArticleId IdType="pubmed">16446100</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.C., Liu L., Ma F., Wong C.W., Guo X.E., Chacko J.V., Farhoodi H.P., Zhang S.X., Zimak J., S&#xe9;galiny A., et al. Elucidation of Exosome Migration Across the Blood&#x2013;Brain Barrier Model In Vitro. Cell. Mol. Bioeng. 2016;9:509&#x2013;529. doi: 10.1007/s12195-016-0458-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12195-016-0458-3</ArticleId><ArticleId IdType="pmc">PMC5382965</ArticleId><ArticleId IdType="pubmed">28392840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer&#x2019;s disease &#x3b2;-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA. 2006;103:11172&#x2013;11177. doi: 10.1073/pnas.0603838103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603838103</ArticleId><ArticleId IdType="pmc">PMC1544060</ArticleId><ArticleId IdType="pubmed">16837572</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman J.M., Fernando S.M., Grad L.I., Hill A.F., Turner B.J., Yerbury J.J., Cashman N.R. Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways. Cell. Mol. Neurobiol. 2016;36:377&#x2013;381. doi: 10.1007/s10571-015-0294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabe Y., Mori K., Yamashita T., Gotoh S., Ikeda M. The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS. EMBO J. 2020;39:e102700. doi: 10.15252/embj.2019102700.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102700</ArticleId><ArticleId IdType="pmc">PMC7527818</ArticleId><ArticleId IdType="pubmed">32830871</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T., Yamashita T., Tamaoka A., Kwak S. Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. Int. J. Mol. Sci. 2019;20:3148. doi: 10.3390/ijms20133148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133148</ArticleId><ArticleId IdType="pmc">PMC6651127</ArticleId><ArticleId IdType="pubmed">31252669</ArticleId></ArticleIdList></Reference><Reference><Citation>De Andrade H.M.T., de Albuquerque M., Avansini S.H., Rocha C.D.S., Dogini D.B., Nucci A., Carvalho B., Lopes-Cendes I., Fran&#xe7;a M.C. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J. Neurol. Sci. 2016;368:19&#x2013;24. doi: 10.1016/j.jns.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman K.S., Toledo J.B., Tsivinsky V.G., Irwin D., Grossman M., Weintraub D., Hurtig H.I., Chen-Plotkin A., Wolk D.A., McCluskey L.F., et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer&#x2019;s Res. Ther. 2017;9:89. doi: 10.1186/s13195-017-0316-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0316-0</ArticleId><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Dolenc Gro&#x161;elj L., Zidar J., Rogelj B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic als patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci. 2018;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I., et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick J., Men Y., Jin S., Seo S., Espejo-Porras F., Yang Y. Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS. Exp. Neurol. 2020;333:113414. doi: 10.1016/j.expneurol.2020.113414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="pubmed">32712030</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M., Hama Y., Utsumi J., Takashina K., Yasumatsu H., Mori F., Wakabayashi K., Shoji M., Sasaki H. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2019;708:134176. doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack S.A., Dunlop R.A., Cox P.A. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: Towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol. 2020;10:200116. doi: 10.1098/rsob.200116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.C., Whitehead A.L., Jacques R.M., Julious S.A. The statistical interpretation of pilot trials: Should significance thresholds be reconsidered? BMC Med. Res. Methodol. 2014;14:41. doi: 10.1186/1471-2288-14-41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-41</ArticleId><ArticleId IdType="pmc">PMC3994566</ArticleId><ArticleId IdType="pubmed">24650044</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1. doi: 10.1186/gb-2002-3-7-research0034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2002-3-7-research0034</ArticleId><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B. 1995;57:289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachos I.S., Zagganas K., Paraskevopoulou M.D., Georgakilas G., Karagkouni D., Vergoulis T., Dalamagas T., Hatzigeorgiou A.G. DIANA-miRPath v3.0: Deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460&#x2013;W466. doi: 10.1093/nar/gkv403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv403</ArticleId><ArticleId IdType="pmc">PMC4489228</ArticleId><ArticleId IdType="pubmed">25977294</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Leigh P.N., Newbury S.F., Hafezparast M. An Overview of MicroRNAs as Biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D., Wajnberg G., Roy J., Beauregard A.P., Chacko S., Crapoulet N., Fournier S., Ghosh A., Lewis S.M., Marrero A., et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:1&#x2013;9. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Robichaud P.P., Arseneault M., O&#x2019;Connell C., Ouellette R.J., Morin P.J. Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis. Neurosci. Lett. 2021;750:135813. doi: 10.1016/j.neulet.2021.135813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.135813</ArticleId><ArticleId IdType="pubmed">33705931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M., Nuzziello N., Introna A., Consiglio A., Licciulli F., D&#x2019;Errico E., Scarafino A., Distaso E., Simone I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;11:288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi Y.H., Wang H. Exploring microRNA biomarker for amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2018;19:1318. doi: 10.3390/ijms19051318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051318</ArticleId><ArticleId IdType="pmc">PMC5983737</ArticleId><ArticleId IdType="pubmed">29710810</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M., Ricci C., Jones A.R., Giannini F., Al-Chalabi A., Battistini S. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. Neuromol. Med. 2016;18:551&#x2013;560. doi: 10.1007/s12017-016-8396-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8396-8</ArticleId><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala J.M., Arias-Carrasco R., Sanchez C., Uhrig M., Bargsted L., Matus S., Maracaja-Coutinho V., Abarzua S., van Zundert B., Verdugo R., et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;64:123&#x2013;138. doi: 10.1016/j.neurobiolaging.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang E.J., Reichardt L.F. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 2001;24:677&#x2013;736. doi: 10.1146/annurev.neuro.24.1.677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.24.1.677</ArticleId><ArticleId IdType="pmc">PMC2758233</ArticleId><ArticleId IdType="pubmed">11520916</ArticleId></ArticleIdList></Reference><Reference><Citation>Alc&#xe1;ntara S., Fris&#xe9;n J., Del R&#xed;o J.A., Soriano E., Barbacid M., Silos-Santiago I. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 1997;17:3623&#x2013;3633. doi: 10.1523/JNEUROSCI.17-10-03623.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.17-10-03623.1997</ArticleId><ArticleId IdType="pmc">PMC6573670</ArticleId><ArticleId IdType="pubmed">9133385</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan J., Noakes P.G., Bellingham M.C. The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2019;13:368. doi: 10.3389/fncel.2019.00368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00368</ArticleId><ArticleId IdType="pmc">PMC6700252</ArticleId><ArticleId IdType="pubmed">31456666</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T., Klausmeyer A., Conrad R., Gottschling C., Leo M., Faissner A., Wiese S. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways. Mol. Cell. Neurosci. 2013;56:18&#x2013;28. doi: 10.1016/j.mcn.2013.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.02.007</ArticleId><ArticleId IdType="pubmed">23500004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P., Kalb R.G. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB. J. Neurochem. 2003;84:1421&#x2013;1430. doi: 10.1046/j.1471-4159.2003.01599.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01599.x</ArticleId><ArticleId IdType="pubmed">12614342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojsilovic-Petrovic J., Jeong G.B., Crocker A., Arneja A., David S., Russell D., Kalb R.G. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J. Neurosci. 2006;26:9250&#x2013;9263. doi: 10.1523/JNEUROSCI.1856-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1856-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674510</ArticleId><ArticleId IdType="pubmed">16957081</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS? Front. Cell. Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva E.V., Ayala V., Jov&#xe9; M., Dalf&#xf3; E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Ot&#xed;n M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130:3111&#x2013;3123. doi: 10.1093/brain/awm190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm190</ArticleId><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C., Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 2017;13:477&#x2013;491. doi: 10.1038/nrneurol.2017.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.99</ArticleId><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro F., Pennuto M. Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases. Front. Mol. Neurosci. 2017;10:82. doi: 10.3389/fnmol.2017.00082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00082</ArticleId><ArticleId IdType="pmc">PMC5374214</ArticleId><ArticleId IdType="pubmed">28408866</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Feuer R., Cashman N., Luo H. Enteroviral infection: The forgotten link to amyotrophic lateral sclerosis? Front. Mol. Neurosci. 2018;11:63. doi: 10.3389/fnmol.2018.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Fernando S.M., Cashman N.R. From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis. Neurobiol. Dis. 2015;77:257&#x2013;265. doi: 10.1016/j.nbd.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.009</ArticleId><ArticleId IdType="pubmed">25701498</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird S.W., Maynard N.D., Covert M.W., Kirkegaard K. Nonlytic viral spread enhanced by autophagy components. Proc. Natl. Acad. Sci. USA. 2014;111:13081&#x2013;13086. doi: 10.1073/pnas.1401437111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401437111</ArticleId><ArticleId IdType="pmc">PMC4246951</ArticleId><ArticleId IdType="pubmed">25157142</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.M., Tsueng G., Sin J., Mangale V., Rahawi S., McIntyre L.L., Williams W., Kha N., Cruz C., Hancock B.M., et al. Coxsackievirus B Exits the Host Cell in Shed Microvesicles Displaying Autophagosomal Markers. PLoS Pathog. 2014;10:e1004045. doi: 10.1371/journal.ppat.1004045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.H., Du W., Hagemeijer M.C., Takvorian P.M., Pau C., Cali A., Brantner C.A., Stempinski E.S., Connelly P.S., Ma H.C., et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160:619&#x2013;630. doi: 10.1016/j.cell.2015.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H.K., Yeo H., Sessions O.M., Yan B., Libau E.A., Howe J.L.C., Lim Z.Q., Suku-Maran S., Ong W.Y., Chua K.B., et al. Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 2016;6:36983. doi: 10.1038/srep36983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>